A retrospective analysis of the Alzheimer's disease vaccine progress - The critical need for new development strategies
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A retrospective analysis of the Alzheimer's disease vaccine progress - The critical need for new development strategies
Authors
Keywords
-
Journal
JOURNAL OF NEUROCHEMISTRY
Volume 137, Issue 5, Pages 687-700
Publisher
Wiley
Online
2016-03-19
DOI
10.1111/jnc.13608
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aβ43 is neurotoxic and primes aggregation of Aβ40 in vivo
- (2015) Sylvie Burnouf et al. ACTA NEUROPATHOLOGICA
- A fresh perspective from immunologists and vaccine researchers: Active vaccination strategies to prevent and reverse Alzheimer's disease
- (2015) Michael G. Agadjanyan et al. Alzheimers & Dementia
- Vanutide Cridificar and the QS-21 Adjuvant in Japanese Subjects with Mild to Moderate Alzheimer’ s Disease: Results from Two Phase 2 Studies
- (2015) Heii Arai et al. Current Alzheimer Research
- Mouse models rarely mimic the transcriptome of human neurodegenerative diseases: A systematic bioinformatics-based critique of preclinical models
- (2015) Terry C. Burns et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Is fucose the answer to the immunomodulatory paradox of Quillaja saponins?
- (2015) Dante J. Marciani INTERNATIONAL IMMUNOPHARMACOLOGY
- Alzheimer's disease vaccine development: A new strategy focusing on immune modulation
- (2015) Dante J. Marciani JOURNAL OF NEUROIMMUNOLOGY
- An N-terminal antibody promotes the transformation of amyloid fibrils into oligomers and enhances the neurotoxicity of amyloid-beta: the dust-raising effect
- (2015) Yu-Hui Liu et al. Journal of Neuroinflammation
- Vaccine-induced Aβ-specific CD8+ T cells do not trigger autoimmune neuroinflammation in a murine model of Alzheimer’s disease
- (2015) Martine Bruley Rosset et al. Journal of Neuroinflammation
- Neuroinflammation in Alzheimer's disease
- (2015) Michael T Heneka et al. LANCET NEUROLOGY
- Decreased amyloid-β and increased neuronal hyperactivity by immunotherapy in Alzheimer's models
- (2015) Marc Aurel Busche et al. NATURE NEUROSCIENCE
- A noninflammatory immune response in aged DNA Aβ42-immunized mice supports its safety for possible use as immunotherapy in AD patients
- (2015) Doris Lambracht-Washington et al. NEUROBIOLOGY OF AGING
- Tailoring the Antibody Response to Aggregated Aß Using Novel Alzheimer-Vaccines
- (2015) Markus Mandler et al. PLoS One
- Tau immunotherapy for Alzheimer's disease
- (2015) Jan Torleif Pedersen et al. TRENDS IN MOLECULAR MEDICINE
- Co-immunization with DNA and protein mixture: A safe and efficacious immunotherapeutic strategy for Alzheimer's disease in PDAPP mice
- (2015) Si Liu et al. Scientific Reports
- Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer’s disease
- (2015) Martin R Farlow et al. Alzheimers Research & Therapy
- A Comparative Evaluation of a Novel Vaccine in APP/PS1 Mouse Models of Alzheimer’s Disease
- (2015) Iván Carrera et al. Biomed Research International
- Biopersistence and Brain Translocation of Aluminum Adjuvants of Vaccines
- (2015) Romain Kroum Gherardi et al. Frontiers in Neurology
- Impact of amyloid β aggregate maturation on antibody treatment in APP23 mice
- (2015) Karthikeyan Balakrishnan et al. Acta Neuropathologica Communications
- The Effects of Soluble A.β Oligomers on Neurodegeneration in Alzheimer's Disease
- (2015) Jonathan Brouillette CURRENT PHARMACEUTICAL DESIGN
- IgG Conformer's Binding to Amyloidogenic Aggregates
- (2015) Monichan Phay et al. PLoS One
- A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease
- (2014) Eric Karran et al. ANNALS OF NEUROLOGY
- Immunotherapy for Alzheimer's disease
- (2014) Thomas Wisniewski et al. BIOCHEMICAL PHARMACOLOGY
- Antibodies and protein misfolding: From structural research tools to therapeutic strategies
- (2014) Erwin De Genst et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- New Th2 adjuvants for preventive and active immunotherapy of neurodegenerative proteinopathies
- (2014) Dante J. Marciani DRUG DISCOVERY TODAY
- A dual vaccine against influenza & Alzheimer's disease failed to enhance anti-β-amyloid antibody responses in mice with pre-existing virus specific memory
- (2014) Hayk Davtyan et al. JOURNAL OF NEUROIMMUNOLOGY
- Passive Immunization with Tau Oligomer Monoclonal Antibody Reverses Tauopathy Phenotypes without Affecting Hyperphosphorylated Neurofibrillary Tangles
- (2014) D. L. Castillo-Carranza et al. JOURNAL OF NEUROSCIENCE
- Animal models of Alzheimer disease: historical pitfalls and a path forward
- (2014) Sarah E. Cavanaugh ALTEX-Alternatives to Animal Experimentation
- A coimmunization vaccine of Aβ42 ameliorates cognitive deficits without brain inflammation in an Alzheimer’s disease model
- (2014) Shuang Wang et al. Alzheimers Research & Therapy
- First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model
- (2014) Eva Kontsekova et al. Alzheimers Research & Therapy
- Active immunotherapy options for Alzheimer’s disease
- (2014) Bengt Winblad et al. Alzheimers Research & Therapy
- Peptide-based vaccines for cancer therapy
- (2014) Giorgio Parmiani et al. Human Vaccines & Immunotherapeutics
- Global Epidemiology of Dementia: Alzheimer’s and Vascular Types
- (2014) Liara Rizzi et al. Biomed Research International
- Affinity Enhancement of Antibodies: How Low-Affinity Antibodies Produced Early in Immune Responses Are Followed by High-Affinity Antibodies Later and in Memory B-Cell Responses
- (2014) H. N. Eisen Cancer Immunology Research
- A canine model of human aging and Alzheimer's disease
- (2013) Elizabeth Head BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Inflammatory components in human Alzheimer’s disease and after active amyloid-β42 immunization
- (2013) Elina Zotova et al. BRAIN
- Pyroglutamate-Modified Amyloid Beta Peptides: Emerging Targets for Alzheimer´s Disease Immunotherapy
- (2013) Roxanna Perez-Garmendia et al. Current Neuropharmacology
- Repeated immunization of mice with phosphorylated-tau peptides causes neuroinflammation
- (2013) Lea Rozenstein-Tsalkovich et al. EXPERIMENTAL NEUROLOGY
- Mechanisms of action of naturally occurring antibodies against β-amyloid on microglia
- (2013) Maike Gold et al. Journal of Neuroinflammation
- Understanding immunosenescence to improve responses to vaccines
- (2013) Jörg J Goronzy et al. NATURE IMMUNOLOGY
- Development of a New DNA Vaccine for Alzheimer Disease Targeting a Wide Range of Aβ Species and Amyloidogenic Peptides
- (2013) Yoh Matsumoto et al. PLoS One
- Neurotoxicity of Amyloid -Protein: Synaptic and Network Dysfunction
- (2013) L. Mucke et al. Cold Spring Harbor Perspectives in Medicine
- DNA vaccines
- (2013) Cevayir Coban et al. Human Vaccines & Immunotherapeutics
- Naturally occurring autoantibodies interfere with β-amyloid metabolism and improve cognition in a transgenic mouse model of Alzheimer’s disease 24 h after single treatment
- (2013) D Mengel et al. Translational Psychiatry
- Polarization of host immune responses by helminth-expressed glycans
- (2012) Smanla Tundup et al. Annals of the New York Academy of Sciences
- Amyloid-β Immunotherapy for Alzheimers Disease
- (2012) H.J. Fu et al. CNS & Neurological Disorders-Drug Targets
- Technologies for enhanced efficacy of DNA vaccines
- (2012) Fadi Saade et al. Expert Review of Vaccines
- Identification of oligomers at early stages of tau aggregation in Alzheimer's disease
- (2012) Cristian A. Lasagna-Reeves et al. FASEB JOURNAL
- Vaccination with a non-human random sequence amyloid oligomer mimic results in improved cognitive function and reduced plaque deposition and micro hemorrhage in Tg2576 mice
- (2012) Suhail Rasool et al. Molecular Neurodegeneration
- Human Anti-Aβ IgGs Target Conformational Epitopes on Synthetic Dimer Assemblies and the AD Brain-Derived Peptide
- (2012) Alfred T. Welzel et al. PLoS One
- Active DNA Aβ42 vaccination as immunotherapy for Alzheimer disease
- (2012) Doris Lambracht-Washington et al. Translational Neuroscience
- Aging, cancer, and cancer vaccines
- (2012) Paolo Mazzola et al. Immunity & Ageing
- Amyloid Structure: Conformational Diversity and Consequences
- (2011) Brandon H. Toyama et al. Annual Review of Biochemistry
- CpG DNA as a vaccine adjuvant
- (2011) Christian Bode et al. Expert Review of Vaccines
- Low-n oligomers as therapeutic targets of Alzheimer’s disease
- (2011) Kenjiro Ono et al. JOURNAL OF NEUROCHEMISTRY
- Soluble Aβ oligomer production and toxicity
- (2011) Megan E. Larson et al. JOURNAL OF NEUROCHEMISTRY
- Autoreactive-Aβ antibodies promote APP β-secretase processing
- (2011) Juan Deng et al. JOURNAL OF NEUROCHEMISTRY
- Naturally Occurring Autoantibodies against -Amyloid: Investigating Their Role in Transgenic Animal and In Vitro Models of Alzheimer's Disease
- (2011) R. Dodel et al. JOURNAL OF NEUROSCIENCE
- Innate immunity and adjuvants
- (2011) S. Akira PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- A Cyclic Undecamer Peptide Mimics a Turn in Folded Alzheimer Amyloid β and Elicits Antibodies against Oligomeric and Fibrillar Amyloid and Plaques
- (2011) Peter Hoogerhout et al. PLoS One
- Anti-amyloidogenic Activity of IgGs Contained in Normal Plasma
- (2010) Brian O’Nuallain et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Active Immunization with Amyloid- 1-42 Impairs Memory Performance through TLR2/4-Dependent Activation of the Innate Immune System
- (2010) P. Vollmar et al. JOURNAL OF IMMUNOLOGY
- An improved method for generating consistent soluble amyloid-beta oligomer preparations for in vitro neurotoxicity studies
- (2010) Deborah A. Ryan et al. JOURNAL OF NEUROSCIENCE METHODS
- Linear and conformation specific antibodies in aged beagles after prolonged vaccination with aggregated Abeta
- (2010) Vitaly Vasilevko et al. NEUROBIOLOGY OF DISEASE
- Stabilization of neurotoxic Alzheimer amyloid- oligomers by protein engineering
- (2010) A. Sandberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibody Responses, Amyloid-β Peptide Remnants and Clinical Effects of AN-1792 Immunization in Patients with AD in an Interrupted Trial
- (2009) Tyler Kokjohn et al. CNS & Neurological Disorders-Drug Targets
- DNA prime–protein boost increased the titer, avidity and persistence of anti-Aβ antibodies in wild-type mice
- (2009) H Davtyan et al. GENE THERAPY
- The Structure of Aβ42 C-Terminal Fragments Probed by a Combined Experimental and Theoretical Study
- (2009) Chun Wu et al. JOURNAL OF MOLECULAR BIOLOGY
- Development of AFFITOPE vaccines for Alzheimer’s disease (AD) — From concept to clinical testing
- (2009) A. Schneeberger et al. Journal of Nutrition Health & Aging
- IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders
- (2009) H. Fillit et al. NEUROLOGY
- Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease
- (2009) M. Britschgi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ISCOMs and ISCOMATRIX™
- (2009) Hong-Xiang Sun et al. VACCINE
- The coming of age of virus-like particle vaccines
- (2008) Gary T. Jennings et al. BIOLOGICAL CHEMISTRY
- Biology of Immune Responses to Vaccines in Elderly Persons
- (2008) Birgit Weinberger et al. CLINICAL INFECTIOUS DISEASES
- Amyloid β-Protein Assembly and Alzheimer Disease
- (2008) Robin Roychaudhuri et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Amyloid-β immunisation for Alzheimer's disease
- (2008) Thomas Wisniewski et al. LANCET NEUROLOGY
- Maleimide conjugation markedly enhances the immunogenicity of both human and murine idiotype-KLH vaccines
- (2008) Kamran Kafi et al. MOLECULAR IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now